Art

J-GLOBAL ID：201802255456922519   Reference number：18A1004240

Effectiveness of Stereotactic Radiotherapy and Bevacizumab for Recurrent High-Grade Gliomas: A Potential Therapy for Isocitrate Dehydrogenase Wild-Type Recurrent High-Grade Gliomas

再発性高悪性度神経膠腫に対する定位放射線療法とベバシズマブの有効性:イソクエン酸デヒドロゲナーゼ野生型再発高悪性度神経膠腫に対する有望な治療法【JST・京大機械翻訳】

Author (16)： Yasuda Takayuki (Department of Neurosurgery, Tokyo Women’s Medical University, Shinjuku-ku, Tokyo, Japan) ,  Muragaki Yoshihiro (Department of Neurosurgery, Tokyo Women’s Medical University, Shinjuku-ku, Tokyo, Japan) ,  Muragaki Yoshihiro (Faculty of Advanced Techno-Surgery, Institute of Biomedical Engineering and Science, Tokyo Women’s Medical University, Shinjuku-ku, Tokyo, Japan) ,  Nitta Masayuki (Department of Neurosurgery, Tokyo Women’s Medical University, Shinjuku-ku, Tokyo, Japan) ,  Nitta Masayuki (Faculty of Advanced Techno-Surgery, Institute of Biomedical Engineering and Science, Tokyo Women’s Medical University, Shinjuku-ku, Tokyo, Japan) ,  Miyamoto Kazunari (Department of Radiation therapy, Itabashi Chuo Medical Center, Itabashi-ku, Tokyo, Japan) ,  Oura Yuko (Department of Radiation therapy, Itabashi Chuo Medical Center, Itabashi-ku, Tokyo, Japan) ,  Henmi Takuo (Department of Pathology, Tokyo Women’s Medical University, Shinjuku-ku, Tokyo, Japan) ,  Noguchi Sanshiro (Department of Pathology, Tokyo Women’s Medical University, Shinjuku-ku, Tokyo, Japan) ,  Oda Hideaki (Department of Pathology, Tokyo Women’s Medical University, Shinjuku-ku, Tokyo, Japan) ,  Saito Taiichi (Department of Neurosurgery, Tokyo Women’s Medical University, Shinjuku-ku, Tokyo, Japan) ,  Maruyama Takashi (Department of Neurosurgery, Tokyo Women’s Medical University, Shinjuku-ku, Tokyo, Japan) ,  Maruyama Takashi (Faculty of Advanced Techno-Surgery, Institute of Biomedical Engineering and Science, Tokyo Women’s Medical University, Shinjuku-ku, Tokyo, Japan) ,  Atsuchi Shoko (Department of Neurosurgery, Itabashi Chuo Medical Center, Itabashi-ku, Tokyo, Japan) ,  Miura Naohisa (Department of Neurosurgery, Itabashi Chuo Medical Center, Itabashi-ku, Tokyo, Japan) ,  Kawamata Takakazu (Department of Neurosurgery, Tokyo Women’s Medical University, Shinjuku-ku, Tokyo, Japan)
Material： World Neurosurgery  (World Neurosurg)
Volume： 114  Page： e1138-e1146  Publication year： 2018 
JST Material Number： A1144A  ISSN： 1878-8750  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Abstract/Point： This study aimed to evaluate t...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1004240&from=J-GLOBAL&jstjournalNo=A1144A") }}

Thesaurus term： *Radiotherapy ,  *wild type ,  patient ,  World Health Organization ,  *isocitrate dehydrogenase ,  *Recurrence ,  median value ,  *glioma ,  prognostic factor
Semi thesaurus term： 単変量解析 ,  生存期間 ,  全生存期間 ,  悪性神経膠腫 ,  *ベバシズマブ ,  *悪性度 , 【Automatic Indexing@JST】

Author keywords (4)： Bevacizumab ,  Isocitrate dehydrogenase mutation ,  Recurrent high-grade glioma ,  Stereotactic radiotherapy

JST classification (2)： Radiotherapy for tumors  (GE03034K) ,  Tumors(=neoplasms)of nervous system  (GN04000V)

Terms in the title (9)： 再発 ,  悪性度 ,  神経膠腫 ,  定位放射線療法 ,  ベバシズマブ ,  有効性 ,  イソクエン酸デヒドロゲナーゼ ,  野生型 ,  治療法